Reconsidering the Trade-offs of Prostate Cancer Screening-Reference-Cited by-同舟云学术

Reconsidering the Trade-offs of Prostate Cancer Screening

Published:2020-06-18 Issue:25 Volume:382 Page:2465-2468
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Shoag Jonathan E.¹,Nyame Yaw A.¹,Gulati Roman¹^ORCID,Etzioni Ruth¹^ORCID,Hu Jim C.¹

Affiliation:

1. From the Department of Urology, Weill Cornell Medicine, New York (J.E.S., J.C.H.); and the Department of Urology, University of Washington (Y.A.N.), and the Division of Public Health Sciences, Fred Hutchinson Cancer Research Center (Y.A.N., R.G., R.E.) — both in Seattle.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMsb2000250

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors improving the diagnostic performance of targeted biopsies in the diagnosis of significant prostate cancer;The French Journal of Urology;2024-12

2. Genetics of prostate cancer: a review of latest evidence;Journal of Medical Genetics;2024-08-13

3. Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer: An Analysis of Real-World Practice Patterns from the CancerLinQ Database;Urologic Oncology: Seminars and Original Investigations;2024-08

4. Prostate cancer screening in Switzerland: a literature review and consensus statement from the Swiss Society of Urology;Swiss Medical Weekly;2024-05-31

5. Ratios of Prostate-Specific Antigen to Albumin, C-reactive Protein, and Haemoglobin Concentration are Valuable Markers to Predict Patients with Either Prostate Cancer or Benign Prostate Hyperplasia;2024-05-30